Viibryd is a prescription drug approved by the Food and Drug Administration (FDA) to treat major depressive disorder. Viibryd is also referred to by its drug name, Vilazodone.
Viibryd is an atypical antidepressant in the serotonergic class. Viibryd is believed to work by changing the balance of neurotransmitters in the brain.
How do I take it?
Viibryd is generally taken once daily.
Viibryd comes in tablet form.
The FDA-approved label for Viibryd lists common side effects including nausea, vomiting, diarrhea, and insomnia.
Rare but serious side effects listed for Viibryd include mania, abnormal bleeding, glaucoma, and serotonin syndrome, which can be fatal.
For more details about this treatment, visit:
Viibryd – Allergan